Stem cell 'therapy' injuries more widespread than we knew

July 29, 2020

Grotesque side effects from unproven 'stem cell' therapies are more common than we realized, reports a team of researchers led by UConn Health in Annals of Neurology on July 29. And despite the dangers, many neurologists feel ill-equipped to warn and educate their patients.

People who have suffered debilitating brain or spinal cord damage, or have been diagnosed with progressive neurological disease, are often frustrated by the lack of treatments available to help them. That frustration can make them easy targets for clinics that inject patients with "stem cells". But most of these clinics are operating outside of the Food and Drug Administration's jurisdiction, and the treatments they offer are unproven. And pricey.

"It's an unethical industry. They use fancy websites promising cures left and right, but which are nothing of the sort. They steal your money but give nothing in return," says Jaime Imitola, senior author of the paper and director of the Comprehensive Multiple Sclerosis Center at UConn Health.

Patients often pay $25,000 to $50,000 in cash for procedures that claim to cure everything from multiple sclerosis to paralysis, but have no evidence to back them up. The clinics, which can operate in the US but are more commonly found in Mexico, China, Russia and other countries with looser health regulations, entice patients to fly out for a week or two of spa-like treatment, physical therapy and injections of stem cells supposedly designed to cure multiple sclerosis, ALS, paralysis, or whatever other neurological impairment the person suffers from. The physical therapy often makes the patient feel better for a week or two. But sadly, there are no treatments that can reliably improve most of these diseases, and definitely none using stem cells. And anecdotal stories have begun popping up of patients who have had these stem cell procedures and then developed horrifying side effects, from hepatitis to nerve pain to bizarre spinal cord tumors.

In an effort to better understand the impact of this stem cell tourism, as the field calls it, a team of researchers lead by UConn Health conducted a nationwide survey of academic neurologists' experiences in stem cell tourism complications. The survey also investigated the level of physician preparation to counsel and educate patients.

Imitola led the study with colleagues from the Ohio State's Neuroscience Research Institute. The researchers know as well as anyone how far medicine is from any kind of stem cell treatment for these neurological diseases. And they have had patients come to them asking for permission--the clinics call it 'clearance'--to get the stem cell injection treatments.

The results of the survey show that bad outcomes from stem cell tourism are much more common than anyone had realized. Of the neurologists who responded to the survey, one in four had had a patient with complications related to stem cell therapy. Patients who had suffered infections, strokes, spinal tumors, seizures, and even deaths were all reported. And 73% of neurologists responding to the survey said they felt that having more educational tools to discuss the issue with patients would be helpful.

"Stem cells hold the promise for patients, not just the desperate ones with terminal illnesses but also those who are looking for a 'natural solution' where modern medicine has failed them. Anecdotally, I have spent many hours talking to patients about powerful new immunotherapies to prevent relapses of multiple sclerosis or neuromyelitis optica; but, when they ask if these therapies will help them walk or see again, I have to admit they won't," says Michael Levy, research director for the division of neuroimmunology and neuroinfectious disease at Massachusetts General Hospital, Harvard Medical School, who was not involved in the study.

Levy says the paper by Imitola and his colleagues found that many neurologists are faced with these questions but most have no experience with stem cell therapies.

"Patients as well as physicians are constantly looking for ways to maintain hope. So if a patient asks about it, the doctor may say 'I encourage them to look into it,'" says Dr. Alfredo Quinones-Hinojosa, the William J. and Charles H. Mayo Professor and chair of Neurologic Surgery at the Mayo Clinic, who was also not involved in the study. "We need to be careful how we as physicians find a balance between giving patients hope and maintaining scientific accuracy to the highest standards."

"It is really shocking that only 28% of board-certified neurologists feel completely prepared to discuss this important issue with their patients," Imitola says. The International Society of Stem Cell Research has information available on their website, but Imitola and his colleagues say there is a need for regular educational sessions on stem cell tourism to be held at international and national neurology meetings as well.

"The ultimate goal of this research is to be able to determine the extent of the complications and the readiness of neurologists to counsel patients. All of us are interested in bringing real stem cells to the clinic, but this process is arduous and requires a great level of rigor and reproducibility," Imitola said.

The team also plans on starting a national patient registry, where physicians can report complications from stem cell tourism procedures so that the medical world and regulators can get a better sense of the extent of the problem, and have more data with which to educate patients. These findings are more pressing now, when some stem cell clinics are even promoting cures for COVID19 with stem cells.
-end-


University of Connecticut

Related Stem Cells Articles from Brightsurf:

SUTD researchers create heart cells from stem cells using 3D printing
SUTD researchers 3D printed a micro-scaled physical device to demonstrate a new level of control in the directed differentiation of stem cells, enhancing the production of cardiomyocytes.

More selective elimination of leukemia stem cells and blood stem cells
Hematopoietic stem cells from a healthy donor can help patients suffering from acute leukemia.

Computer simulations visualize how DNA is recognized to convert cells into stem cells
Researchers of the Hubrecht Institute (KNAW - The Netherlands) and the Max Planck Institute in Münster (Germany) have revealed how an essential protein helps to activate genomic DNA during the conversion of regular adult human cells into stem cells.

First events in stem cells becoming specialized cells needed for organ development
Cell biologists at the University of Toronto shed light on the very first step stem cells go through to turn into the specialized cells that make up organs.

Surprising research result: All immature cells can develop into stem cells
New sensational study conducted at the University of Copenhagen disproves traditional knowledge of stem cell development.

The development of brain stem cells into new nerve cells and why this can lead to cancer
Stem cells are true Jacks-of-all-trades of our bodies, as they can turn into the many different cell types of all organs.

Healthy blood stem cells have as many DNA mutations as leukemic cells
Researchers from the Princess Máxima Center for Pediatric Oncology have shown that the number of mutations in healthy and leukemic blood stem cells does not differ.

New method grows brain cells from stem cells quickly and efficiently
Researchers at Lund University in Sweden have developed a faster method to generate functional brain cells, called astrocytes, from embryonic stem cells.

NUS researchers confine mature cells to turn them into stem cells
Recent research led by Professor G.V. Shivashankar of the Mechanobiology Institute at the National University of Singapore and the FIRC Institute of Molecular Oncology in Italy, has revealed that mature cells can be reprogrammed into re-deployable stem cells without direct genetic modification -- by confining them to a defined geometric space for an extended period of time.

Researchers develop a new method for turning skin cells into pluripotent stem cells
Researchers at the University of Helsinki, Finland, and Karolinska Institutet, Sweden, have for the first time succeeded in converting human skin cells into pluripotent stem cells by activating the cell's own genes.

Read More: Stem Cells News and Stem Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.